Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1RN | P18510 | 8/20 | 0.67 |
| ▸ | ERAP2 | Q6P179 | 8/20 | 0.67 |
| ▸ | MMP1 | P03956 | 7/20 | 0.58 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP8 | P22894 | 2/20 | 0.57 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.57 |
| ▸ | NMBR | P28336 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | TACR1 | P25103 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14486061 | 0.93 | IL1RN (0.62) | IL1RNERAP2MMP1MMP2MMP8 | |
| SCHEMBL29531545 | 0.87 | ERAP2 (0.73) | IL1RNERAP2ERAP1 | |
| SCHEMBL29531276 | 0.87 | ERAP2 (0.73) | IL1RNERAP2ERAP1 | |
| SCHEMBL30051546 | 0.87 | ERAP2 (0.73) | IL1RNERAP2ERAP1 | |
| SCHEMBL30051905 | 0.87 | ECE1 (0.69) | IL1RNERAP2MMP1MMP2MMP8 | |
| SCHEMBL29538468 | 0.86 | ERAP2 (0.69) | IL1RNERAP2ERAP1 | |
| Hydrochloric Acid SCHEMBL8613789 | 0.86 | NMBR (0.65) | IL1RNERAP2MMP2MMP8ERAP1 | |
| SCHEMBL31247322 | 0.85 | ERAP2 (0.66) | IL1RNERAP2ERAP1 | |
| SCHEMBL30052459 | 0.85 | ECE1 (0.61) | IL1RNERAP2MMP1MMP2MMP8 | |
| SCHEMBL30051718 | 0.84 | ERAP2 (0.64) | IL1RNERAP2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011017537-A2 | HIGH THROUGHPUT SCREEN FOR MEASURING MEMBRANE EFFECTS | CORNELL UNIVERSITY (US) | 2011-02-10 | — | — | WO | disclosed |